David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VGR
2376
DELISTED
Vector Group Ltd.
VGR
| $1.36M | ﹤0.01% |
186,770
+163,362
| +698% | +$1.21M |
|
|
SC
2377
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $1.35M | ﹤0.01% |
64,063
-158,942
| -71% | -$3.17M |
|
|
SWCH
2378
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $1.35M | ﹤0.01% |
+130,615
| New | +$1.13M |
|
|
BEST
2379
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $1.34M | ﹤0.01% |
12,853
+11,552
| +888% | +$1.2M |
|
2380
CALL
Valmont Industries
VMI
$9.38B
| $1.34M | ﹤0.01% |
10,300
+6,400
| +164% | +$826K |
|
|
ALXN
2381
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.34M | ﹤0.01% |
9,900
-1,700
| -15% | -$211K |
|
|
INVX
2382
Innovex International
INVX
$1.98B
| $1.33M | ﹤0.01% |
28,957
-72,057
| -71% | -$2.83M |
|
|
ROCC
2383
CALL
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $1.33M | ﹤0.01% |
30,100
-12,600
| -30% | -$675K |
|
2384
Box
BOX
$4.73B
| $1.32M | ﹤0.01% |
+68,338
| New | +$1.42M |
|
|
IPG
2385
DELISTED
Interpublic Group of Companies
IPG
| $1.32M | ﹤0.01% |
62,830
-88,438
| -58% | -$1.97M |
|
|
BZUN
2386
Baozun
BZUN
$176M
| $1.32M | ﹤0.01% |
31,760
-5,478
| -15% | -$192K |
|
|
FCRD
2387
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $1.32M | ﹤0.01% |
200,937
+146,146
| +267% | +$982K |
|
|
I
2388
DELISTED
INTELSAT S. A.
I
| $1.32M | ﹤0.01% |
84,020
-209,842
| -71% | -$4.45M |
|
2389
American Express
AXP
$225B
| $1.31M | ﹤0.01% |
12,019
+1,362
| +13% | +$143K |
|
2390
Domo
DOMO
$182M
| $1.31M | ﹤0.01% |
32,557
+14,576
| +81% | +$447K |
|
2391
Lexicon Pharmaceuticals
LXRX
$1.02B
| $1.31M | ﹤0.01% |
236,121
-32,355
| -12% | -$197K |
|
|
IMGN
2392
DELISTED
Immunogen Inc
IMGN
| $1.31M | ﹤0.01% |
+483,839
| New | +$2.1M |
|
2393
PUT
Insmed
INSM
$27.1B
| $1.31M | ﹤0.01% |
45,000
| – | – |
|
2394
Old Dominion Freight Line
ODFL
$41.1B
| $1.31M | ﹤0.01% |
27,153
-10,533
| -28% | -$492K |
|
|
WLH
2395
PUT
DELISTED
WILLIAM LYON HOMES
WLH
| $1.31M | ﹤0.01% |
85,000
| – | – |
|
2396
CALL
VF Corp
VFC
$5.45B
| $1.3M | ﹤0.01% |
15,930
-25,276
| -61% | -$1.97M |
|
2397
Lands' End
LE
$371M
| $1.3M | ﹤0.01% |
78,144
+57,792
| +284% | +$985K |
|
|
NVMI
2398
Nova
NVMI
$12.1B
| $1.3M | ﹤0.01% |
+51,529
| New | +$1.25M |
|
2399
PUT
Deutsche Bank
DB
$75.9B
| $1.3M | ﹤0.01% |
159,700
-128,200
| -45% | -$1.12M |
|
2400
CALL
Alaska Air
ALK
$4.78B
| $1.3M | ﹤0.01% |
23,100
-10,800
| -32% | -$659K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.